Home
>
National Drug Code (NDC)
>
Topotecan
Topotecan - 66758-051-03 - (Topotecan)
Drug Information of Topotecan
| Product NDC: | 66758-051 |
| Proprietary Name: | Topotecan |
| Non Proprietary Name: | Topotecan |
| Active Ingredient(s): | 1 mg/mL & nbsp; Topotecan |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Topotecan
| Product NDC: | 66758-051 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200199 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110225 |
Package Information of Topotecan
| Package NDC: | 66758-051-03 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (66758-051-03) > 3 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Topotecan
| NDC Code | 66758-051-03 |
| Proprietary Name | Topotecan |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (66758-051-03) > 3 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 66758-051 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Topotecan |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110225 |
| Marketing Category Name | NDA |
| Labeler Name | Sandoz Inc |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
